How do non-recurring charges typically affect valuation multiples?

This question is from BIWS and that answer says most of the time these charges effectively increase valuation multiples because they reduce metrics such as EBITE, EBITDA, and EPS. What I'm confused on is I thought we exclude nonrecurring charges when calculating EBITDA. Or is that only in the case when we're calculating for FCF?

3 Comments
 
Most Helpful

If you're looking at a raw multiple, an increase in non-recurring/extraordinary expenses will increase the unadjusted multiple because it decreases the denominator(earnings, and sometimes EBITDA depending on where the company buries the expense). However, databases will often provide an adjusted/normalized multiple to account for items such as non-recurring expenses. You always want to use an adjusted/normalized multiple because most of the time, you are looking at valuing a business on its normal operations as a going concern.

For example, company A is looking to sell itself. EV of company A is 100M, with 10M in unadjusted earnings. It's raw P/E would be 10x. However, this past fiscal year it was hit with a 10M restructuring expense that isn't recurring and/or part of its normal operations. Therefore, the normalized earnings would be $20M if we add the restructuring charge back, indicating that the adjusted/normalized P/E is actually 5x.

The purpose of the exercise is to compare apples to apples when spreading comps, and to get an accurate sense of recurring cash flows when doing a cash flow valuation such as a DCF.

 

Inventore corrupti et accusamus provident. Natus reiciendis eos maxime fugiat mollitia mollitia non. Aspernatur aliquam aperiam aut et sequi. A eos inventore quia assumenda non aspernatur tenetur quidem. Magni blanditiis voluptatem veritatis modi. Voluptate velit aperiam neque est recusandae ad. Fugiat vitae veritatis accusantium dolorum tempore pariatur deleniti perspiciatis.

Odit rerum ipsam inventore. Neque sed ut dicta maiores voluptatem qui et. Impedit error ducimus est earum distinctio dolorem. Aspernatur qui porro illum iure.

Et consequatur est dolore labore ad reprehenderit. Provident non aut aliquam et laboriosam nihil ex.

Career Advancement Opportunities

June 2026 Investment Banking

  • Evercore 01 99.4%
  • Moelis & Company 01 98.9%
  • JPMorgan 01 98.3%
  • Guggenheim Partners 01 97.7%
  • Morgan Stanley 07 97.1%

Overall Employee Satisfaction

June 2026 Investment Banking

  • Moelis & Company No 99.4%
  • Morgan Stanley 02 98.8%
  • Evercore 01 98.3%
  • BMO Capital Markets 12 97.7%
  • Banco Santander 01 97.1%

Professional Growth Opportunities

June 2026 Investment Banking

  • Evercore 01 99.4%
  • Moelis & Company 01 98.9%
  • Morgan Stanley 06 98.3%
  • JPMorgan 01 97.7%
  • Goldman Sachs 02 97.1%

Total Avg Compensation

June 2026 Investment Banking

  • Vice President (14) $434
  • Associates (44) $258
  • 3rd+ Year Analyst (8) $210
  • 2nd Year Analyst (22) $179
  • Intern/Summer Associate (13) $156
  • 1st Year Analyst (79) $150
  • Intern/Summer Analyst (73) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
BankonBanking's picture
BankonBanking
99.0
3
kanon's picture
kanon
99.0
4
Secyh62's picture
Secyh62
99.0
5
CompBanker's picture
CompBanker
98.9
6
GameTheory's picture
GameTheory
98.9
7
Betsy Massar's picture
Betsy Massar
98.9
8
dosk17's picture
dosk17
98.9
9
DrApeman's picture
DrApeman
98.9
10
bolo up's picture
bolo up
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”